Recent Updates
Recently added Catalysts
MDAI Positive Sentiment Score: 70/100

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

Key Takeaway: Spectral AI, a developer focused on medical diagnostics, announced that it will report its second-quarter financial results on August 12, 2025. The company will conduct a conference call to discuss these results, which will be accessible via phone and online webcast. Spectral AI's DeepView System aims to enhance wound care management by providing clinicians with immediate assessments of burn wounds. The goal of this technology is to revolutionize treatment decisions and improve patient care efficiency.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of scheduled financial results can indicate transparency and accountability.
  • Expected discussion of the DeepView System's impact on wound care shows innovation potential.
  • Focus on improving patient outcomes and reducing healthcare costs reflects a positive mission.

Full Press Release Details

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 12, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.
Investors interested in participating in the live call can dial:
412-317-1837 – International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact:
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp

Frequently Asked Questions

When will Spectral AI report its Q2 financial results?

Spectral AI will report its Q2 financial results on August 12, 2025.

How can investors join the conference call?

Investors can dial 412-317-1837 to join the live conference call.

What is the focus of Spectral AI's DeepView System?

The DeepView System focuses on improving wound care with faster diagnostics.

What technology does the DeepView System utilize?

The DeepView System uses AI to provide objective assessments of burn wounds.

Where can I find more information about the DeepView System?

More information is available at www.spectral-ai.com.

Last updated: Jul 30, 2025